Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.

Ann Neurol · 2016 · PMC4825405 · PMID 26814620

Europe PMC DOI

hedged sentence

0.0521

closest p · 1.0× alpha

0.0521

boldest claim

The sentences

a marginal trend toward significancep = 0.0521so close (0.05 < p ≤ 0.1)

Improvements in the score for the physical health domain of the WHOQOL‐BREF in the BTX‐A group showed a marginal trend toward significance ( p = 0.0521) at 4 weeks after the injection.

also in 37 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.